#USA #Radnor #Algeness #Aesthetic Technologies #Lanzhou Biotechnique

Advanced Aesthetic Technologies Celebrates a Milestone in China

Advanced Aesthetic Technologies, Inc. (AAT) recently made headlines with the announcement that their partner in China has received regulatory approval to market the Algeness® VL agarose facial injection filler. This exciting development stems from the hard work between AAT and Lanzhou Biotechnique Development Co., Ltd. (LanDev), the aesthetic sector of China National Biotec Group Company Limited. This is a significant achievement, as Algeness® VL is the first agarose-based dermal filler to be officially sanctioned for sale in China.

Algeness® VL is crafted from a 2.5% agarose gel, designed to provide patients with a natural and effective approach to combating wrinkles and restoring volume to facial features. This innovative product has emerged from years of rigorous scientific research and clinical trials. AAT’s multidisciplinary team of scientists and healthcare professionals worked meticulously to ensure that Algeness® meets safety and efficacy standards, leading to the creation of a completely biodegradable and biocompatible injectable implant.

Doug Abel, the President and CEO of AAT, expressed his thrill regarding the product's entry into the expansive Chinese aesthetic market. He stated, "LanDev is an exceptional partner, given their rich expertise and market presence as the only domestic Chinese producer of botulinum toxin. Their existing product, Hengli, has a substantial market footprint, positioning them as the ideal vehicle to launch Algeness® in China." This approval is viewed as a landmark achievement for both AAT and its collaborative teams at LanDev and CNBG.

Dr. Omer Buhsem, a plastic surgeon from Istanbul and Medical Director for Algeness®, praised the product's unique rheological properties, stating that it offers aesthetic practitioners an indispensable tool for achieving desired results. He emphasized his commitment to safe and effective patient care, bolstered by the impressive safety profile that comes with Algeness®. His extensive experience has showcased the filler’s positive outcomes for over 700 patients in his practice.

The filling agent has garnered significant attention for delivering natural-looking results. Renowned dermatologist Dr. Tatjana Pavicic from Munich stated, "Algeness® is revolutionary within aesthetic medicine, lauded for its natural composition and biocompatibility. After nearly a decade of usage, my patients consistently report high satisfaction due to the quick results and durability of the effects. The product has proven itself with an outstanding safety record."

This approval in China comes on the heels of multiple significant milestones AAT has achieved in the past two years, including:

• - Advancing clinical trials for US FDA Pre-Market Authorization (PMA).
• - Securing CE Mark under stringent Medical Device Regulations (MDR) for therapeutic claims, later expounding to include aesthetic claims.
• - Acquiring a controlling stake in Ghimas, S.p.A., the original innovator behind Algeness®.

The market entry into China is a pivotal moment for AAT, especially with anticipation building for potential US approval. With a strong regulatory framework and encouraging clinical data, AAT is laying the groundwork for Algeness® to secure an important role in the global aesthetic medicine landscape.

Overview of Algeness®

Algeness® represents the apex of AAT’s innovations in aesthetic medicine, emphasizing results that are not only effective but also sustainably sourced. Unlike many fillers that rely on synthetic additives, Algeness® is entirely derived from natural agarose, ensuring an eco-friendly option for cosmetic procedures. Plans for broader market availability are in motion, as AAT aims to enhance accessibility to this pioneering filler in both domestic and international markets.

As AAT forges ahead, expectations mount for the transformative impact of Algeness® in the expanding arena of aesthetic treatments, promising a future where natural and effective solutions take center stage.

To learn more about Algeness® and its revolutionary capabilities, visit Algeness.com.